An experimental medication that was recently shown to slow the progression of the neurodegenerative disease amyotrophic lateral sclerosis (ALS) has now demonstrated the potential to also prolong patient survival. The findings come from a clinical trial conducted by investigators at the Sean M. Healey & AMG Center for ALS at Harvard-afilliated Massachusetts General Hospital (MGH)… Read More: New drug prolongs ALS patient survival in trial »
Health News Loading the player… LONDON (AP) — U.K. researchers are preparing to infect healthy young volunteers with the virus that causes COVID-19, becoming the first to announce plans to use the controversial technique to study the disease and potentially speed up development of a vaccine that could help end the pandemic. This type of… Read More: UK to infect healthy volunteers in vaccine research trial »
Sometimes in oncology, where both the unmet need and the level of competition are high, when you see a signal, you go for it. Taking on a bit more risk to head into phase 3 can make sense “because the patients are waiting and the business opportunity is in front of you,” as one Pfizer… Read More: ESMO: Pfizer, Merck KGaA’s Bavencio comes up short against placebo… »
Article content continued The episode was typical of what has become a serious problem in the COVID-19 pandemic: misinterpretation of trial data, with “disastrous” results for other studies, Mills and colleagues argue in a recent medical journal commentary. Influenced by media accounts, scientific oversight boards often don’t recognize there are distinct phases to COVID-19 sickness,… Read More: Authorities misinterpreting COVID-19 trial data with ‘disastrous’ results, Canadian researchers… »